Associations
newsletter
subscribe
advertise
contact
Technology
pulseTV
Buyer's Guide
Comparison Charts
Blogs
Events
Webinars
Magazine
Cardiac Diagnostics
ECG
ECG Management Systems
Holter Monitoring Systems
Stress Test Systems
Cardiac Imaging
Advanced Visualization
Angiography Systems
Cardiovascular Ultrasound
Contrast Media
CT Systems
Hybrid OR
MRI Systems
Nuclear Imaging
Cath Lab
Angiography Systems
Balloon Catheters
Hemostasis Management
Intravascular Imaging Systems
Interventional Radiology
Hybrid OR
Radial Access
Stents
Ventricular Assist Devices (VAD)
EP Lab
Ablation Systems
Cardiac Resynchronization Therapy Devices (CRT)
Implantable Cardioverter Defibrillators (ICD)
Leads, implantable devices
Pacemakers
Information Technology
Advanced Visualization
Cardiac PACS
Telecardiology
Structural Heart
Heart Valve Repair
Hybrid OR
Left Atrial Appendage (LAA) Occluders
Structural Heart Occluders/Closure Devices
BioVentrix
Related Articles
Heart Failure Treatments
BioVentrix Receives CE Mark for Myocardial Anchoring System
Heart Failure Patients Show Improvement With Device That Reshapes Heart
Catheter-Deployed Device Reduces LV Volume in Heart Failure Patients
Cath Lab
BioVentrix Receives CE Mark for Myocardial Anchoring System
Structural Heart
BioVentrix Receives CE Mark for Myocardial Anchoring System
Catheter-Deployed Device Reduces LV Volume in Heart Failure Patients
Clinical Trial/Study
Heart Failure Patients Show Improvement With Device That Reshapes Heart
Structural Heart Occluders/Closure Devices
Catheter-Deployed Device Reduces LV Volume in Heart Failure Patients
Cardiovascular Surgery
Jury Renders Alleged Patent Infringement “Willful”
